New eye drops promise quick redness relief
NCT ID NCT06444529
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a special eye drop (apraclonidine) can safely reduce eye redness caused by minor irritations. 159 adults who often use redness-relief drops took part. Researchers measured redness before and after using the drops, checking at 15 minutes and 10 hours later. The goal was to see if the drops work better than a placebo (fake drops).
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULAR REDNESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emerson Clinical Research Institute, Inc.
Falls Church, Virginia, 22046, United States
-
Global Research Management
Glendale, California, 91204, United States
-
Oculus Research, Inc.
Garner, North Carolina, 27529, United States
-
Piedmont Eye Center
Lynchburg, Virginia, 24502, United States
-
Scott & Christie and Associates, PC
Cranberry Township, Pennsylvania, 16066, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.